Analysis of Survival Rate and Influencing Factors in Surgical Treatment of Primary Hepatocellular Carcinoma

Authors

  • Jianfei Wu
  • Guodong Yu
  • Xixi Tian
  • Quan Zhang

DOI:

https://doi.org/10.54097/6yjb4825

Keywords:

Primary Hepatocellular Carcinoma, Survival Rate, Independent Risk Factors

Abstract

Objective: To study the survival rate of patients with primary hepatocellular carcinoma (HCC) undergoing clinical surgical treatment and various influencing factors, with the aim of further improving the survival rate of primary HCC patients. Methods: Sixty patients with primary hepatocellular carcinoma who underwent liver cancer resection surgery between January 2020 and December 2022 in our hospital were selected. A retrospective analysis was conducted on the patients' clinical characteristics (family medical history, alpha-fetoprotein levels, degree of liver cirrhosis, vascular invasion), treatment methods (surgical techniques, adjunctive therapies), and prognosis. The survival rate of patients and the influencing factors on the postoperative survival rate were analyzed. Results: There was a statistically significant difference in the five-year survival rate comparisons between different liver cirrhosis statuses, tumor sizes, preoperative alpha-fetoprotein levels, vascular invasion statuses, adjunctive treatment methods, and family medical histories (P < 0.05). Comparisons between different genders, ages, tumor locations, tumor pathological types, hepatitis B surface antigens, Child-Pugh classifications of liver function, tumor numbers, and methods of liver cancer resection showed no statistically significant differences (P > 0.05). Liver cirrhosis, tumor size ≥ 5cm, preoperative alpha-fetoprotein level > 400ng/ml, change in alpha-fetoprotein levels pre-and post-surgery, vascular invasion, adjunctive treatment methods, and PLC family medical history are independent factors influencing the survival rate of surgical treatment in primary HCC patients. Conclusion: There are several factors affecting the postoperative survival rate of primary HCC patients. Clinicians need to take a comprehensive approach. For high-risk patients, regular follow-ups are necessary, coupled with early diagnosis and treatment, to improve the prognosis. This approach is worth promoting. 

Downloads

Download data is not yet available.

References

Lu Yuan, Lu Wei. Clinical analysis of 23 cases of primary liver cancer treated by operation [J]. Jilin Medicine,2014, 35 (02): 291-293.

Wang He, He Lei, Dong Jiahong. Prognostic factors of surgical treatment for primary liver cancer [J]. Journal of Naval Medicine,2017,38(01):43-45+53. (in Chinese)

Shao W S, Xiao J W. Clinical effect analysis of 60 cases of primary liver cancer treated by operation [J]. Jilin Medicine, 2016, 37(05):1038-1040. (in Chinese)

Song Pinghui, Zhou Niulei. Effect of different hepatic blood flow blocking protocols on surgical treatment of large liver cancer [J]. Chinese Journal of General Surgery (electronic edition), 2016,10(02):168-170. (in Chinese)

Li Xingchen, Zhao Jianjun, Bi Xinyu et al. Long-term survival of large hepatocellular carcinoma after surgical resection with comprehensive treatment [J]. Journal of Hepatocellular Carcinoma Electronic,2019,6(03):28-30.

Ye Haiwen, Deng Yong, Zhang Lingqiang et al. Effect of HBV DNA load on surgical treatment of hepatocellular carcinoma associated with hepatitis B [J]. Journal of Hepatobiliary diseases, 2018,34(09):1995-1998.

LUO Xuan-ming, ZHAO Jin-ming, BAI Lei et al. Key technical points of surgical treatment of primary liver cancer [J]. Xinjiang Med,2018,48(05):555-557+563. (in Chinese)

SHANG Changyou, Yu Jiaxin, YAN Lifu et al. Effect of group Morita therapy on quality of life in patients with hepatocellular carcinoma undergoing surgical treatment [J]. Sichuan Mental Health, 2019,33(04):335-338. (in Chinese)

Li Li. Analysis of influencing factors on quality of life of patients with primary liver cancer undergoing surgical treatment [J]. Xinjiang Medicine, 2019,50(07):718-720.

Cao Hongwei, Li Saihua, Hu Hailong. Study on survival rate and influencing factors after surgical treatment of primary liver cancer [J]. Chinese Journal of Health Standards Management, 2019, 10(24):17-20. (in Chinese)

LV Yongfeng, Chen Qingxia, Li Guocheng et al. Effect of ulinastatin on immune function of patients with malignant pleural fluid after liver cancer surgery treated by fluorouracil implantation [J]. Journal of Chengdu Medical College,2011,6 (03): 254-256.

Ma Pengyu, Qi Yan, Wang Hong et al. Effect of body temperature control on hypermetabolism in patients with hepatocellular carcinoma treated by high-intensity focused ultrasound [J]. Hebei Medicine,2013,35(03):366-367.

CHU Zhiqiang, Wu Xiangwei, Yang Hongqiang et al. Analysis of survival rate and influencing factors after surgical treatment of primary liver cancer [J]. Journal of Practical Medicine, 2013, 29 (05): 787-789. (in Chinese)

Xu Jianbo, Qi Fuzhen, Xu Gang et al. Effect analysis of surgical and radiofrequency ablation for primary small and medium-sized liver cancer [J]. Modern Oncology Medicine, 2013, 21(08):1822-1825. (in Chinese)

Lu Y, Lu W. Clinical analysis of 23 cases of primary liver cancer treated by operation [J]. Jilin Medicine,2014, 35 (02): 291-293.

Downloads

Published

22-02-2024

Issue

Section

Articles

How to Cite

Wu, J., Yu, G., Tian, X., & Zhang, Q. (2024). Analysis of Survival Rate and Influencing Factors in Surgical Treatment of Primary Hepatocellular Carcinoma. International Journal of Biology and Life Sciences, 5(1), 5-8. https://doi.org/10.54097/6yjb4825